Effect of ADC4022 Co-Administered With Budesonide on Pulmonary Inflammation in Subjects With Moderate to Severe COPD
Status:
Completed
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the tolerability and efficacy of inhaled theophylline
(ADC4022) on markers of pulmonary inflammation (white blood cells) in induced sputum and in
bronchial biopsy samples in subjects with moderate to severe Chronic Obstructive Pulmonary
Disease (COPD) when co-administered with budesonide and compared to placebo.